AI Article Synopsis
Article Abstract
A quantitative study of lymphoid cells in the B- and T-cell-dependent areas of intestinal lymphoid nodules and mesenteric lymph nodes in behaviorally passive and active rats was performed at various periods after acute stress on the model of 1-h immobilization with simultaneous electrocutaneous stimulation. Stress exposure is accompanied by a decrease in the number of lymphoid cells in immunogenic structures of the gastrointestinal tract. Post-stress changes in the cytoarchitectonics of B- and T-cell-dependent areas in mesenteric lymph nodes of animals are less pronounced than in lymphoid nodules. Quantitative changes in lymphoid cells of B-cell-dependent areas in the small intestine of rats are greater than in T-cell-dependent areas. Changes in the cellular composition of immunogenic structures in the digestive system are most significant at the early stages of the post-stress period (1st week). Passive rats are characterized by significant changes in the cytoarchitectonics of B- and Tcell-dependent areas in the small intestine after extreme exposure, which illustrates functional exhaustion of the lymphoid tissue in stress-predisposed specimens.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10517-018-4002-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mosunetuzumab for the treatment of follicular lymphoma.
Expert Opin Biol Ther
October 2024
Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.
Introduction: Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma that shows a progressive increase in relapses and refractory in its natural history and a median survival of approximately 18-20 years. The advent of anti-CD20 monoclonal antibodies has changed the FL therapeutic algorithm, with an increase in progression-free survival. T-cell-dependent bispecific antibodies (BsAbs) represent an emerging drug class against FL.
View Article and Find Full Text PDFChallenges and gaps in immunosafety evaluation of therapeutics: An IQ DruSafe survey.
Regul Toxicol Pharmacol
June 2024
Merck & Co., West Point, PA, USA.
Immunotoxicology/immunosafety science is rapidly evolving, with novel modalities and immuno-oncology among the primary drivers of new tools and technologies. The Immunosafety Working Group of IQ/DruSafe sought to better understand some of the key challenges in immunosafety evaluation, gaps in the science, and current limitations in methods and data interpretation. A survey was developed to provide a baseline understanding of the needs and challenges faced in immunosafety assessments, the tools currently being applied across the industry, and the impact of feedback received from regulatory agencies.
View Article and Find Full Text PDFA mechanistic marker-based screening tool to predict clinical immunogenicity of biologics.
Commun Med (Lond)
December 2023
Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, 14214, USA.
Background: The efficacy and safety of therapeutic proteins are undermined by immunogenicity driven by anti-drug antibodies. Immunogenicity risk assessment is critically necessary during drug development, but current methods lack predictive power and mechanistic insight into antigen uptake and processing leading to immune response. A key mechanistic step in T-cell-dependent immune responses is the migration of mature dendritic cells to T-cell areas of lymphoid compartments, and this phenomenon is most pronounced in the immune response toward subcutaneously delivered proteins.
View Article and Find Full Text PDFA CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4 T-cell-dependent strain-transcending protective immunity in rodent models.
mBio
December 2023
Institute for Glycomics, Griffith University, Southport, Queensland, Australia.
Malaria is a devastating disease that has claimed many lives, especially children <5 years of age in Sub-Saharan Africa, as documented in World Malaria Reports by WHO. Even though vector control and chemoprevention tools have helped with elimination efforts in some, if not all, endemic areas, these efforts have been hampered by serious issues (including drug and insecticide resistance and disruption to social cohesion caused by the COVID-19 pandemic). Development of an effective malaria vaccine is the alternative preventative tool in the fight against malaria.
View Article and Find Full Text PDFRegulation of immune response against third-stage larvae by human genes.
Front Immunol
August 2023
Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Background: Gnathostomiasis is an important zoonosis in tropical areas that is mainly caused by third-stage larvae ( L3).
Objectives: This study aimed to prove whether L3 produces extracellular vesicles (EVs) and investigate human gene profiles related to the immune response against the larvae.
Methods: We created an immune cell model using normal human peripheral blood mononuclear cells (PBMCs) co-cultured with the larvae for 1 and 3 days, respectively.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!